At the end of January, SGD Pharma, a global leader in glass primary packaging for the pharmaceutical industry, started a two-week trial using 100% hydrogen burners for industrial-scale glass production. The trial, conducted at SGD Pharma’s state-of-the-art Saint-Quentin-Lamotte (SQLM) manufacturing plant in France, was a resounding success and will inform SGD Pharma’s decarbonization roadmap which aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040.

SGD Pharma, a global leader in glass pharmaceutical packaging, has achieved a gold medal in EcoVadis’ 2024 sustainability ratings. Building upon previous years, SGD Pharma’s score of 78 puts the business in the 98^th percentile for manufacturers of glass and glass products.